Interestingly, the anti-cancer drug L-asparaginase harbors an intrinsic glutaminase activity and induces, through this glutaminase activity, a marked inhibition of mTORC1 and produces a pronounced apoptotic response in primary AML cells [227] (Figure 6). The gene discussed is GLS; the disease is acute myeloid leukemia.